Track the Episurf Medical AB stock price and the full management transaction log of the company, a publicly traded company based in Finland. Shares are quoted on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, Episurf Medical AB has recorded 12 insider filings. Market capitalisation: €408.2m. The latest transaction was reported on 9 July 2026 (Sale). Among the most active insiders: Mofast AB (Publ). The full history is free.
12
Insider Decl.
n/a
Thresholds
€7m
5 ops.
Buy Volume
€19,690
1 ops.
Sell Volume
46Σ signal
Buys €7m€19,690 Sells
Fundamental score
Ranked 21,437 of 29,064 companies
35.6
score / 100
Value
21
Quality
50
FCF yld-5.4%
Earn yld-5.1%
EV/EBITDA·
ROE-28%
Gross mgn75%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
2,381,542 shares@ €0.01610.0044% mcap68.9% of flowOptionISINISIN SE0025667470FI:A003R756-1
12 of 12 declarations
Acerca de Episurf Medical AB
Episurf Medical AB es una empresa enfocada en el desarrollo de soluciones médicas para lesiones articulares. Se concentra en tratamientos innovadores para mejorar la calidad de vida de los pacientes.